Figure 12From: Occurrence of genetic modifications in core, 5′UTR and NS5b of HCV associated with viral response to treatment Potential N-glycosylation sites in core protein sequence predicted from SignalP-NN: (A) group I (with SVR); (B) group 2 (non-responders). Back to article page